156 related articles for article (PubMed ID: 27342220)
1. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.
Schomaker M; Leroy V; Wolfs T; Technau KG; Renner L; Judd A; Sawry S; Amorissani-Folquet M; Noguera-Julian A; Tanser F; Eboua F; Navarro ML; Chimbetete C; Amani-Bosse C; Warszawski J; Phiri S; N'Gbeche S; Cox V; Koueta F; Giddy J; Sygnaté-Sy H; Raben D; Chêne G; Davies MA;
Int J Epidemiol; 2017 Apr; 46(2):453-465. PubMed ID: 27342220
[TBL] [Abstract][Full Text] [Related]
2. Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.
Schomaker M; Davies MA; Malateste K; Renner L; Sawry S; N'Gbeche S; Technau KG; Eboua F; Tanser F; Sygnaté-Sy H; Phiri S; Amorissani-Folquet M; Cox V; Koueta F; Chimbete C; Lawson-Evi A; Giddy J; Amani-Bosse C; Wood R; Egger M; Leroy V;
Epidemiology; 2016 Mar; 27(2):237-46. PubMed ID: 26479876
[TBL] [Abstract][Full Text] [Related]
3. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
Leroy V; Malateste K; Rabie H; Lumbiganon P; Ayaya S; Dicko F; Davies MA; Kariminia A; Wools-Kaloustian K; Aka E; Phiri S; Aurpibul L; Yiannoutsos C; Signaté-Sy H; Mofenson L; Dabis F;
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):208-19. PubMed ID: 23187940
[TBL] [Abstract][Full Text] [Related]
5. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
6. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
7. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
[TBL] [Abstract][Full Text] [Related]
8. Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.
Jesson J; Koumakpaï S; Diagne NR; Amorissani-Folquet M; Kouéta F; Aka A; Lawson-Evi K; Dicko F; Kouakou K; Pety T; Renner L; Eboua T; Coffie PA; Desmonde S; Leroy V;
Pediatr Infect Dis J; 2015 Jul; 34(7):e159-68. PubMed ID: 25955835
[TBL] [Abstract][Full Text] [Related]
9. Malnutrition, Growth Response and Metabolic Changes Within the First 24 Months After ART Initiation in HIV-infected Children Treated Before the Age of 2 Years in West Africa.
Jesson J; Dahourou DL; Amorissani Folquet M; Malateste K; Yonaba C; N'Gbeche MS; Ouédraogo S; Mea-Assande V; Amani-Bossé C; Blanche S; Timité-Konan M; Leroy V;
Pediatr Infect Dis J; 2018 Aug; 37(8):781-787. PubMed ID: 29406463
[TBL] [Abstract][Full Text] [Related]
10. Impact of antiretroviral treatment on height evolution of HIV infected children.
Traisathit P; Urien S; Le Coeur S; Srirojana S; Akarathum N; Kanjanavanit S; Ngampiyaskul C; Krikajornkitti S; Ngo-Giang-Huong N; Lallemant M; Jourdain G
BMC Pediatr; 2019 Aug; 19(1):287. PubMed ID: 31421667
[TBL] [Abstract][Full Text] [Related]
11. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.
Fenner L; Brinkhof MW; Keiser O; Weigel R; Cornell M; Moultrie H; Prozesky H; Technau K; Eley B; Vaz P; Pascoe M; Giddy J; Van Cutsem G; Wood R; Egger M; Davies MA;
J Acquir Immune Defic Syndr; 2010 Aug; 54(5):524-32. PubMed ID: 20588185
[TBL] [Abstract][Full Text] [Related]
12. Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017.
Iyun V; Technau KG; Eley B; Rabie H; Boulle A; Fatti G; Egger M; Tanser F; Wood R; Fairlie L; Cotton MF; Davies MA
Pediatr Infect Dis J; 2020 Feb; 39(2):127-133. PubMed ID: 31725119
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis.
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
J Int AIDS Soc; 2020 Apr; 23(4):e25477. PubMed ID: 32297485
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs.
Davies MA; May M; Bolton-Moore C; Chimbetete C; Eley B; Garone D; Giddy J; Moultrie H; Ndirangu J; Phiri S; Rabie H; Technau KG; Wood R; Boulle A; Egger M; Keiser O;
Pediatr Infect Dis J; 2014 Jun; 33(6):608-16. PubMed ID: 24378936
[TBL] [Abstract][Full Text] [Related]
15. Immunologic outcomes of antiretroviral therapy among HIV-infected Nigerian children and its association with early infant feeding and nutritional status at treatment initiation.
Omoni AO; Christian PS; Sadoh WE; Okechukwu A; Olateju E; Omoigberale A; Blattner W; Charurat ME
Pediatr Infect Dis J; 2013 Jul; 32(7):e291-7. PubMed ID: 23411626
[TBL] [Abstract][Full Text] [Related]
16. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia.
Boettiger DC; Aurpibul L; Hudaya DM; Fong SM; Lumbiganon P; Saphonn V; Truong KH; Hansudewechakul R; Nguyen LV; Do VC; Bunupuradah T; Chokephaibulkit K; Nik Yusoff NK; Kumarasamy N; Wati DK; Razali KA; Kariminia A;
Pediatr Infect Dis J; 2016 May; 35(5):e144-51. PubMed ID: 26835972
[TBL] [Abstract][Full Text] [Related]
18. Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.
Desmonde S; Dicko F; Koueta F; Eboua T; Balestre E; Amani-Bosse C; Aka EA; Lawson-Evi K; Amorissani-Folquet M; Kouakou K; Koumakpai S; Renner L; Signaté Sy H; Leroy V;
AIDS; 2014 Jul; 28(11):1645-55. PubMed ID: 24804858
[TBL] [Abstract][Full Text] [Related]
19. Outcome of anti-retroviral treatment in HIV-infected orphans and non-orphans at an ART centre in North India.
Bhattacharya M; Saxena R
Paediatr Int Child Health; 2012; 32(4):228-32. PubMed ID: 23164297
[TBL] [Abstract][Full Text] [Related]
20. Growth in the first 5 years after antiretroviral therapy initiation among HIV-infected children in the IeDEA West African Pediatric Cohort.
Jesson J; Ephoevi-Ga A; Desmonde S; Ake-Assi MH; D'Almeida M; Sy HS; Malateste K; Amorissani-Folquet M; Dicko F; Kouadio K; Renner L; Leroy V;
Trop Med Int Health; 2019 Jun; 24(6):775-785. PubMed ID: 30945378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
